1.
Adrienne A. Phillips, Paul A. Fields, Olivier Hermine, Juan C. Ramos, Brady E. Beltran, Juliana Pereira, Farooq Wandroo, Tatyana Feldman, Graham P. Taylor, Ahmed Sawas, Jeffrey Humphrey, Michael Kurman, Junji Moriya, Karen Dwyer, Mollie Leoni, Kevin Conlon, Lucy Cook, Jason Gonsky, Steven M. Horwitz. Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma. haematol [Internet]. 2019May1 [cited 2023Feb.1];104(5):993-1003. Available from: https://haematologica.org/article/view/8902